Andres Roblesgil‐Medrano
Papers
2
Total Citations
41
H-Index
2
About
Andres Roblesgil‐Medrano is a rising figure in urologic oncology and minimally invasive surgery, whose work is shaping the future of robotic-assisted procedures. His research centers on comparing the efficacy and safety of novel surgical platforms, particularly the da Vinci Single-Port (SP) system, against established multiport and laparoscopic techniques. His most impactful contribution is a seminal systematic review and meta-analysis on single-port versus multiport robotic-assisted radical prostatectomy for prostate cancer, which has garnered 26 citations and provides critical evidence on the SP console’s application since its FDA approval in 2018. Additionally, his meta-analysis comparing robotic-assisted to laparoscopic living donor nephrectomy for renal transplantation, with 15 citations, offers valuable insights into optimizing outcomes for end-stage renal disease patients. By synthesizing data from multiple studies, Roblesgil‐Medrano has helped clarify the advantages of these advanced approaches, influencing surgical decision-making. His work is notable for its rigorous methodology and direct relevance to improving patient care, establishing him as a key voice in the evolution of robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2